Filing Details
- Accession Number:
- 0001181431-11-010274
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-15 13:38:28
- Reporting Period:
- 2011-02-11
- Filing Date:
- 2011-02-15
- Accepted Time:
- 2011-02-15 13:38:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
820096 | Perrigo Co | PRGO | Pharmaceutical Preparations (2834) | 382799573 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1353986 | Ran Gottfried | C/O Perrigo Company 515 Eastern Avenue Allegan MI 49010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-02-11 | 5,814 | $16.77 | 15,800 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-02-11 | 5,814 | $73.07 | 9,986 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Director Stock Option Right to Buy | Disposition | 2011-02-11 | 5,814 | $0.00 | 5,814 | $16.77 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2007-11-10 | 2016-11-10 | No | 4 | M | Direct |
Footnotes
- The price in column 4 is a weighted average. The prices actually received ranged from $73.055 to $73.073. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.